Pharmaco - Press Releases

Date	Title	Company
15-May-2020	BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020	BioPharmX Corporation
15-May-2020	Penumbra, Inc. Announces Virtual 2020 Annual Meeting of Stockholders	Penumbra, Inc.
15-May-2020	Government supports small labs to help ramp up COVID-19 testing for frontline health and care workers	Sciad Newswire
14-May-2020	DefiniGEN launches tool for coronavirus-specific intestinal cell research	DefiniGEN
14-May-2020	MorphoSys and Incyte Announce Long-term Follow-up Results from L-MIND Study of Tafasitamab in Patients with r/r DLBCL (news with additional features)	MorphoSys AG
14-May-2020	Calliditas Publicly Files Registration Statement With SEC for a Proposed Initial Public Offering in the United States	Calliditas Therapeutics
14-May-2020	SciMount announces FDA approval of SMP-100's IND application for the treatment of Irritable Bowel Syndrome	Chengdu SciMount Pharmatech, Co. Ltd.
14-May-2020	Clinigen Signs Exclusive Agreement with Xeris Pharmaceuticals to Supply and Distribute Gvoke™ Outside the US	B3C newswire
14-May-2020	4basebio AG: 4basebio AG reports first quarter 2020 financial results	4basebio AG
14-May-2020	Business development of Vita 34 stable and unaffected by COVID-19 development so far	Vita 34 AG
14-May-2020	Vivoryon Therapeutics AG: Vivoryon Therapeutics AG Reports First Quarter 2020	Vivoryon Therapeutics AG
14-May-2020	EVOTEC SE REPORTS FIRST QUARTER 2020 RESULTS AND PROVIDES CORPORATE UPDATE	Evotec SE
14-May-2020	Polyphor announces acceptance of balixafortide abstract at the American Society of Clinical Oncology (ASCO) 2020 virtual scientific program	Polyphor AG
14-May-2020	STRATEC POSTS DYNAMIC START TO FINANCIAL YEAR 2020	STRATEC SE
14-May-2020	ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model	ABIVAX
14-May-2020	Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial	ABIVAX
14-May-2020	Halodine® Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19)	Veloce BioPharma LLC
13-May-2020	Janssen's BCMA CAR-T Therapy JNJ-4528 Showed Early, Deep and Durable Responses in Heavily Pretreated Patients with Multiple Myeloma	The Janssen Pharmaceutical Companies of Johnson & Johnson
13-May-2020	ERLEADA® (apalutamide) Significantly Improved Overall Survival in Patients with Non-Metastatic Castration-Resistant Prostate Cancer	Janssen Oncology
13-May-2020	Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes	MEI Pharma, Inc.